At the heart of Scotland’s innovation in sensor technology is Novosound, a groundbreaking company founded in 2018 as the University of the West of Scotland’s first spinout.

With an initial £500k in funding from the Scottish Enterprise High Growth spin-out process, Novosound has revolutionised the field with its pioneering approach to printable ultrasound sensors. The company’s advanced thin-film technology, developed through its in-house design and manufacturing expertise, provides a flexible, temperature-resistant, lightweight, and compact core material capable of high-resolution imaging. This cutting-edge solution positions Novosound at the forefront of ultrasound sensor technology and underscores Glasgow’s growing influence in high-tech innovation.

Based at BioCity, Novosound serves a diverse range of sectors including Oil and Gas, Aerospace, and Semiconductors with its advanced sensors for ultrasonic non-destructive testing. The company is also innovating with new technologies, including:

Since its inception, Novosound has expanded to 30 staff and achieved a six-figure turnover. With a vision to expand into medical imaging and wearable markets, Novosound is poised to capitalise on the projected growth of the global NDT market ($7.3 billion), medical imaging ($10.46 billion), and wearables ($27 billion), collectively valued at $44.76 billion by 2022.